Takeda Products Ireland Ltd
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PROTIUM gastro-resistant tablet 20 mg
- PROTIUM gastro-resistant tablet 40 mg
- PROTIUM IV powder for solution for injection 40 mg
- D06 - Antibióticos y quimioterápicos para uso dermatológico
- CONDYLINE cutaneous solution 0.5%
- L02 - Terapia endocrina
- PROSTAP 3 DCS PREFILLED SYRINGE powder and solvent for suspension for injection 11.25 mg+2 ml
- PROSTAP 6 DCS PREFILLED SYRINGE powder and solvent for suspension for injection 30 mg+2 ml
- PROSTAP SR DCS PREFILLED SYRINGE powder and solvent for suspension for injection 3.75 mg+1 ml
- N02 - Analgésicos
- MATRIFEN transdermal patch 100 µg/h
- MATRIFEN transdermal patch 12 µg/h
- MATRIFEN transdermal patch 25 µg/h
- MATRIFEN transdermal patch 50 µg/h
- MATRIFEN transdermal patch 75 µg/h